Vein of Galen aneurysmal malformation: rationalizing medical management of neonatal heart failure

被引:21
作者
Cory, Melinda J. [1 ]
Durand, Phillippe [2 ]
Sillero, Rafael [3 ]
Morin, Luc [2 ]
Savani, Rashmin [4 ]
Chalak, Lina [4 ]
Angelis, Dimitrios [4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Cardiol, Dallas, TX USA
[2] Paris Saclay Univ Hosp, AP HP, Div Pediat & Neonatal Intens Care, Bicetre Med Ctr, Paris, France
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Neurosurg, Dallas, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Div Neonatal Perinatal Med, Dallas, TX 75390 USA
关键词
VENA-CAVA FLOW; SEVERE CARDIAC-FAILURE; ARTERIOVENOUS MALFORMATION; DEVELOPMENTAL-CHANGES; NITRIC-OXIDE; MILRINONE; DOBUTAMINE; DOPAMINE; INFANTS; HEMODYNAMICS;
D O I
10.1038/s41390-022-02064-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neonates who present in high output heart failure secondary to vein of Galen aneurysmal malformation can be difficult to manage medically due to the complex physiology that results from the large shunt through the malformation. Though the cardiac function is often normal, right ventricular dilation, severe pulmonary hypertension, and systemic steal can result in inadequate organ perfusion and shock. This report recommends medical management for stabilization of neonates prior to definitive management with endovascular embolization. Impact Vein of Galen aneurysmal malformation (VGAM) is a rare intracranial arteriovenous malformation, which can present in the neonatal period with high output heart failure. Heart failure secondary to VGAM is often difficult to manage and is associated with high mortality and morbidity. Despite optimal medical management, many patients require urgent endovascular embolization for stabilization of their heart failure. This report offers discrete recommendations that can be used by clinicians as guidelines for the medical management of heart failure in newborns with VGAM.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 75 条
[1]   DEVELOPMENTAL-CHANGES IN MODULATION OF CALCIUM CURRENTS OF RABBIT VENTRICULAR CELLS BY PHOSPHODIESTERASE INHIBITORS [J].
AKITA, T ;
JOYNER, RW ;
LU, CB ;
KUMAR, R ;
HARTZELL, HC .
CIRCULATION, 1994, 90 (01) :469-478
[2]   Fetal and Neonatal MRI Predictors of Aggressive Early Clinical Course in Vein of Galen Malformation [J].
Arko, L. ;
Lambrych, M. ;
Montaser, A. ;
Zurakowski, D. ;
Orbach, D. B. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2020, 41 (06) :1105-1111
[3]   INOTROPIC RESPONSES CHANGE DURING POSTNATAL MATURATION IN RABBIT [J].
ARTMAN, M ;
KITHAS, PA ;
WIKE, JS ;
STRADA, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (02) :H335-H342
[4]   Anesthetic management of a neonate with vein of Galen aneurysmal malformations and severe pulmonary hypertension [J].
Ashida, Y ;
Miyahara, H ;
Sawada, H ;
Mitani, Y ;
Maruyama, K .
PEDIATRIC ANESTHESIA, 2005, 15 (06) :525-528
[5]   A BLIND, RANDOMIZED COMPARISON OF THE CIRCULATORY EFFECTS OF DOPAMINE AND EPINEPHRINE INFUSIONS IN THE NEWBORN PIGLET DURING NORMOXIA AND HYPOXIA [J].
BARRINGTON, KJ ;
FINER, NN ;
CHAN, WKY .
CRITICAL CARE MEDICINE, 1995, 23 (04) :740-748
[6]   THE EFFECT OF MILRINONE ON SPLANCHNIC AND CEREBRAL PERFUSION IN INFANTS WITH CONGENITAL HEART DISEASE PRIOR TO SURGERY: AN OBSERVATIONAL STUDY [J].
Bianchi, Maria Otilia ;
Cheung, Po-Yin ;
Phillipos, Ernest ;
Aranha-Netto, Abimael ;
Joynt, Chloe .
SHOCK, 2015, 44 (02) :115-120
[7]   Vasopressin for Refractory Hypotension in Extremely Low Birth Weight Infants [J].
Bidegain, Margarita ;
Greenberg, Rachel ;
Simmons, Catherine ;
Dang, Chi ;
Cotten, C. Michael ;
Smith, P. Brian .
JOURNAL OF PEDIATRICS, 2010, 157 (03) :502-504
[8]   DEVELOPMENTAL-CHANGES IN THE CARDIAC EFFECTS OF AMRINONE IN THE DOG [J].
BINAH, O ;
LEGATO, MJ ;
DANILO, P ;
ROSEN, MR .
CIRCULATION RESEARCH, 1983, 52 (06) :747-752
[9]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[10]   Role of nonglycosidic inotropic agents: indications, ethics, and limitations [J].
Chatterjee, K ;
De Marco, T .
MEDICAL CLINICS OF NORTH AMERICA, 2003, 87 (02) :391-+